Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease characterized by lung fibrosis and declining lung function. There are currently few effective treatments for IPF, and the median survival following diagnosis ...
Apr 7, 2016
0
6
Idiopathic pulmonary fibrosis (IPF) is a chronic adult lung disease in which normal lung tissue is slowly replaced by scar tissue, affecting seven to 16 of every 100,000 Americans. Though the name is similar, IPF differs ...
Mar 7, 2016
0
0
Idiopathic pulmonary fibrosis is a devastating disease, and recently approved therapies have limited efficacy. Lungs become damaged with fibrotic scarring, and the median length of survival after diagnosis is three to five ...
Feb 24, 2016
0
1
After evaluating content on idiopathic pulmonary fibrosis on almost 200 websites, researchers with medical backgrounds found that the information on IPF from these sites was often incomplete, inaccurate and outdated. The ...
Feb 5, 2016
0
1
Scientists of the Comprehensive Pneumology Center (CPC) at the Helmholtz Zentrum München have identified a new mechanism which contributes to the development of idiopathic pulmonary fibrosis (IPF). They showed that the pathological ...
Jul 27, 2015
0
9
Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) have been released by an international group of leading respiratory societies, The new guidelines, issued by the American Thoracic Society, the European ...
Jul 15, 2015
0
15
Idiopathic pulmonary fibrosis (IPF) causes a gradual loss of respiratory capacity and can be lethal within a few years. The cause is unknown, although it can be attributed to a combination of genetics and the environment. ...
Jul 2, 2015
0
29
A new study shows that shorter telomeres—which are the protective caps at the end of a cell's chromosomes—are linked with worse survival in a progressive respiratory disease called idiopathic pulmonary fibrosis (IPF). ...
Jun 15, 2015
0
5
Researchers at Helmholtz Zentrum München, in collaboration with an international team, have identified a potential novel drug target for idiopathic pulmonary fibrosis, a dangerous chronic lung disease. They elucidated a ...
Jun 8, 2015
0
164
(HealthDay)—Articles relating to diffuse parenchymal lung disease, asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary diagnostics, and respiratory infections are included in a special update summary ...
May 9, 2015
0
17
